Today, diabetes affects more than 101 million people in India. It is estimated that by 2045, the number will reach 125 million. Related to diabetes, such as heart disease, chronic renal disease and diabetic retinopathy (DR). While other symptoms usually present other risks, DR is a vision complication that endangers diabetic complications and usually progresses quietly, leading to visual impairment and in some cases blindness. This is the first factor in global vision loss in middle-aged adults.
The Smart India study conducted across multiple states and one union field examined the prevalence of more than 6,000 people with diabetes and revealed that the prevalence of retinopathy was 12.5%. Of this, 4% of people suffer from threatening diabetic retinopathy (VTDR), which leads to full vision loss. Small blood vessels in the retina may swell and leak due to prolonged high blood sugar causes DR, or they may close, preventing blood from passing and leading to progressive vision loss. DR usually has no early symptoms. As a result, most patients remain unaware of this condition and therefore inadvertently allow it to develop to an advanced stage.
Hyderabad said Dr Padmaja Kumari Rani, deputy director of networks at Vitreetretinal Services, consultant for LV Prasad Eye Institute, said “Diabetic retinopathy (DR) is a preventable complication of diabetes. If I were diagnosed at an early stage, I could better manage the complications of diabetes. Regular eye examinations are essential. Detection of early signs of retinopathy is so crucial that diabetes can be treated in time in nearly three patients, but the variability due to the disease has caused damage to the damage or damage to the agkia. Long-term high blood sugar levels are progressive but irreversible, so timely intervention is crucial.”
To address this risk, the Diabetes Research Association of India (RSSDI) and the Vitr Retinal Society of India (VRSI) jointly developed guidelines that recommend regular screening of all patients with diabetes. They highlight the importance of annual ophthalmic examinations and point to the importance of early detection and rapid intervention to prevent VTDR3. It is recommended that patients with type 1 diabetes have screened for five years from the year of diagnosis, and type 2 patients should be screened for at the time of diagnosis. In addition, due to the increased risk of DR progression during pregnancy, pregnant women with diabetes need a tailored screening schedule. Since vision loss is irreversible, active DR screening is important, just like the routine blood tests used for diabetes monitoring.
Screening tools, such as non-capillary bottom cameras equipped with artificial intelligence (AI) algorithms, can be screened quickly and efficiently, making it easier for doctors to identify patients who need ophthalmic references.[6]. Through early detection, public awareness and comprehensive screening models, DR can be widely managed. Collaboration among healthcare providers and their collaboration with patients will help retain millions of dollars in sight for this silent complication of diabetes.
